GUIDED THERAPEUTICS INC (GTHP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300K 600K 900K Q3 '24: 38K Q4 '24: 7K Q1 '25: 1K Q2 '25: 118K Q3 '25: 178K Q4 '25: 767K Q1 '26: 767K Q2 '26: 650K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

-200K 0 200K 400K 600K Q3 '24: 20K Q4 '24: 2K Q1 '25: -2K Q2 '25: 77K Q3 '25: 112K Q4 '25: 572K Q1 '26: 572K Q2 '26: 493K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q3 '24: -2.1M Q4 '24: -2.1M Q1 '25: -2.2M Q2 '25: -2.3M Q3 '25: -2.2M Q4 '25: -2.4M Q1 '26: -2.3M Q2 '26: -2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -1.7M Q4 '24: -2M Q1 '25: -2.4M Q2 '25: -2.5M Q3 '25: -2.6M Q4 '25: -3.2M Q1 '26: -3.3M Q2 '26: -3.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 70K 140K 210K Q3 '24: 18K Q4 '24: 5K Q1 '25: 3K Q2 '25: 41K Q3 '25: 66K Q4 '25: 195K Q1 '26: 195K Q2 '26: 157K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '24: -1.1M Q4 '24: -1.1M Q1 '25: -1.4M Q2 '25: -1.3M Q3 '25: -1.1M Q4 '25: -1.1M Q1 '26: -1.4M Q2 '26: -1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q1 '22: -1.5M Q2 '22: -1.1M Q3 '22: -1M Q4 '22: -1.5M Q1 '23: -1.8M Q2 '23: -1.9M Q3 '23: -1.8M Q4 '23: -1.7M Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '24: 54.8M Q2 '24: 56M Q3 '24: 57M Q1 '25: 68.3M Q2 '25: 78.8M Q3 '25: 81.7M Q1 '26: 88.8M Q2 '26: 96.5M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.18 -0.12 -0.06 0.00 0.06 0.12 0.18 Q3 '22: -0.16 Q4 '22: -0.16 Q1 '25: -0.05 Q2 '25: -0.05 Q3 '25: -0.05 Q4 '25: -0.04 Q1 '26: -0.04 Q2 '26: -0.04 Q3 '22 Q4 '22 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.